These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33403597)

  • 1. PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.
    D'Amico AG; Maugeri G; Musumeci G; Reglodi D; D'Agata V
    J Mol Neurosci; 2021 Aug; 71(8):1525-1535. PubMed ID: 33403597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of the PACAP-ADNP axis on SOD1G93A mutant motor neuron death induced by trophic factors deprivation.
    Magrì B; D'Amico AG; Maugeri G; Morello G; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
    Neuropeptides; 2023 Dec; 102():102386. PubMed ID: 37856900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.
    Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J
    Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PACAP promotes neuron survival in early experimental diabetic retinopathy.
    Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
    Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACAP-ADNP axis prevents outer retinal barrier breakdown and choroidal neovascularization by interfering with VEGF secreted from retinal pigmented epitelium cells.
    D'Amico AG; Maugeri G; Magrì B; Lombardo C; Saccone S; Federico C; Cavallaro P; Giunta S; Bucolo C; D'Agata V
    Peptides; 2023 Oct; 168():171065. PubMed ID: 37495040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
    D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
    J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic and retinoprotective functions of PACAP.
    Shioda S; Takenoya F; Wada N; Hirabayashi T; Seki T; Nakamachi T
    Anat Sci Int; 2016 Sep; 91(4):313-24. PubMed ID: 27324639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroprotective role of PACAP, VIP, and PHI in the central nervous system].
    Sokołowska P; Dejda A; Nowak JZ
    Postepy Hig Med Dosw (Online); 2004; 58():416-27. PubMed ID: 15577749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
    Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
    J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
    Maugeri G; D'Amico AG; Bucolo C; D'Agata V
    Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
    Dejda A; Sokołowska P; Nowak JZ
    Pharmacol Rep; 2005; 57(3):307-20. PubMed ID: 15985713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.
    Castorina A; Giunta S; Scuderi S; D'Agata V
    J Mol Neurosci; 2012 Nov; 48(3):674-83. PubMed ID: 22454142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse.
    Endo K; Nakamachi T; Seki T; Kagami N; Wada Y; Nakamura K; Kishimoto K; Hori M; Tsuchikawa D; Shinntani N; Hashimoto H; Baba A; Koide R; Shioda S
    J Mol Neurosci; 2011 Jan; 43(1):22-9. PubMed ID: 20703829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
    Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A
    Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
    Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
    Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of PACAP in ischemia.
    Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
    J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.